Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lasse H. Andersen"'
Autor:
Anne Lene Kjældgaard, Jonathan White, Klaus J. Thornberg, Nicolai Haase, Jørn Wetterslev, Lone Musaeus Poulsen, Morten Steensen, Peter Søe-Jensen, Kristian Rørbæk Madsen, Morten Hylander Møller, Lasse H. Andersen, Gudmundur Klemenzson, Per Winkel, Jørgen Wiis, Anders Perner, Morten H. Bestle, Kristian Strand, Lars Broksø Holst, Robert Winding, Maria Louise Fabritius, Pawel Berezowicz, Lars Quist, Katrin Thormar, Frank Christian Pott, Jeanie M. Elkjær, Jonas B. Nielsen, Asger Bendtsen, Frederik Mondrup, Anne Berit Guttormsen, Jyrki Tenhunen, Anders Aneman, Thea Palsgaard Møller
Publikováno v:
Perner, A, Haase, N, Guttormsen, A B, Tenhunen, J, Klemenzson, G, Åneman, A, Madsen, K R, Møller, M, Elkjær, J M, Poulsen, L M, Bendtsen, A O, Winding, R, Steensen, M, Berezowicz, P, Søe-Jensen, P, Bestle, M H, Strand, K, Wiis, J, White, J O, Thornberg, K J, Quist, L, Nielsen, J V, Andersen, L H, Holst, L, Thormar, K, Kjældgaard, A-L, Fabritius, M L, Mondrup, F, Pott, F C, Møller, T P, Winkel, P, Wetterslev, J & 6S Trial Group 2012, ' Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis ', The New England Journal of Medicine, vol. 367, no. 2, pp. 124-34 . https://doi.org/10.1056/NEJMoa1204242
A B S T R AC T Background Hydroxyethyl starch (HES) is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis. Methods In this multicenter, parallel-gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::314e24795dbb1a9583c1051d8078bfef
https://doi.org/10.1056/nejmoa1204242
https://doi.org/10.1056/nejmoa1204242
Autor:
Lars B, Holst, Nicolai, Haase, Jørn, Wetterslev, Jan, Wernerman, Anne B, Guttormsen, Sari, Karlsson, Pär I, Johansson, Anders, Aneman, Marianne L, Vang, Robert, Winding, Lars, Nebrich, Helle L, Nibro, Bodil S, Rasmussen, Johnny R M, Lauridsen, Jane S, Nielsen, Anders, Oldner, Ville, Pettilä, Maria B, Cronhjort, Lasse H, Andersen, Ulf G, Pedersen, Nanna, Reiter, Jørgen, Wiis, Jonathan O, White, Lene, Russell, Klaus J, Thornberg, Peter B, Hjortrup, Rasmus G, Müller, Morten H, Møller, Morten, Steensen, Inga, Tjäder, Kristina, Kilsand, Suzanne, Odeberg-Wernerman, Brit, Sjøbø, Helle, Bundgaard, Maria A, Thyø, David, Lodahl, Rikke, Mærkedahl, Carsten, Albeck, Dorte, Illum, Mary, Kruse, Per, Winkel, Anders, Perner, J M, Breider
Publikováno v:
Holst, L B, Haase, N, Wetterslev, J, Wernerman, J, Guttormsen, A B, Karlsson, S, Johansson, P I, Aneman, A, Vang, M L, Winding, R, Nebrich, L, Nibro, H L, Rasmussen, B S, Lauridsen, J R M, Nielsen, J S, Oldner, A, Pettilä, V, Cronhjort, M B, Andersen, L H, Pedersen, U G, Reiter, N, Wiis, J, White, J O, Russell, L, Thornberg, K J, Hjortrup, P B, Müller, R G, Møller, M H, Steensen, M, Tjäder, I, Kilsand, K, Odeberg-Wernerman, S, Sjøbø, B, Bundgaard, H, Thyø, M A, Lodahl, D, Mærkedahl, R, Albeck, C, Illum, D, Kruse, M, Winkel, P, Perner, A & TRISS Trial Group 2014, ' Lower versus higher hemoglobin threshold for transfusion in septic shock ', The New England Journal of Medicine, vol. 371, no. 15, pp. 1381-91 . https://doi.org/10.1056/NEJMoa1406617
Holst, L B, Haase, N, Wetterslev, J, Wernerman, J, Guttormsen, A B, Karlsson, S, Johansson, P I, Aneman, A, Vang, M L, Winding, R, Nebrich, L, Nibro, H L, Rasmussen, B S, Lauridsen, J R M, Nielsen, J S, Oldner, A, Pettilä, V, Cronhjort, M B, Andersen, L H, Pedersen, U G, Reiter, N, Wiis, J, White, J O, Russell, L, Thornberg, K J, Hjortrup, P B, Müller, R G, Møller, M H, Steensen, M, Tjäder, I, Kilsand, K, Odeberg-Wernerman, S, Sjøbø, B, Bundgaard, H, Thyø, M A, Lodahl, D, Mærkedahl, R, Albeck, C, Illum, D, Kruse, M, Winkel, P, Perner, A & the TRISS Trial Group and the Scandinavian Critical Care Trials Group 2014, ' Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock ', The New England Journal of Medicine, vol. 371, no. 15, pp. 1381-1391 . https://doi.org/10.1056/NEJMoa1406617
Holst, L B, Haase, N, Wetterslev, J, Wernerman, J, Guttormsen, A B, Karlsson, S, Johansson, P I, Aneman, A, Vang, M L, Winding, R, Nebrich, L, Nibro, H L, Rasmussen, B S, Lauridsen, J R M, Nielsen, J S, Oldner, A, Pettilä, V, Cronhjort, M B, Andersen, L H, Pedersen, U G, Reiter, N, Wiis, J, White, J O, Russell, L, Thornberg, K J, Hjortrup, P B, Müller, R G, Møller, M H, Steensen, M, Tjäder, I, Kilsand, K, Odeberg-Wernerman, S, Sjøbø, B, Bundgaard, H, Thyø, M A, Lodahl, D, Mærkedahl, R, Albeck, C, Illum, D, Kruse, M, Winkel, P, Perner, A & the TRISS Trial Group and the Scandinavian Critical Care Trials Group 2014, ' Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock ', The New England Journal of Medicine, vol. 371, no. 15, pp. 1381-1391 . https://doi.org/10.1056/NEJMoa1406617
BACKGROUND: Blood transfusions are frequently given to patients with septic shock. However, the benefits and harms of different hemoglobin thresholds for transfusion have not been established.METHODS: In this multicenter, parallel-group trial, we ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b1f29c139143ec8ca22bfee88055b4
https://pubmed.ncbi.nlm.nih.gov/27686348
https://pubmed.ncbi.nlm.nih.gov/27686348
Autor:
Thomas Mohr, J Asger Petersen, Christian Østergaard, Morten Steensen, Anne Øberg Lauritsen, Paul Christian Fjeldborg, Lars Hein, Jesper Kjaer, Jesper Løken, Sine Hougaard, Pernille L. Petersen, Peter Søe-Jensen, Søren Hestad, Lasse H. Andersen, Mads H. Andersen, Klaus J. Thornberg, Katrin Thormar, Teit Mantoni, Peder Carl, Morten H. Bestle, Bettina Lundgren, Jens-Ulrik Stæhr Jensen, Bonnie Bømler, Charlotte Dahl Rossau, Hamid Tousi, Carsten B Thomsen, Kim M Larsen, Jesper Grarup, Jens D Lundgren
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 8, Iss 1, p 91 (2008)
Jensen, J-U, Lundgren, B, Hein, L, Mohr, T, Petersen, P L, Andersen, L H, Lauritsen, A O, Hougaard, S, Mantoni, T, Bømler, B, Thornberg, K J, Thormar, K, Løken, J, Steensen, M, Carl, P, Petersen, J A, Tousi, H, Søe-Jensen, P, Bestle, M, Hestad, S, Andersen, M H, Fjeldborg, P, Larsen, K M, Rossau, C D, Thomsen, C B, Ostergaard, C, Kjaer, J, Grarup, J & Lundgren, J D 2008, ' The Procalcitonin And Survival Study (PASS)-a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients ', B M C Infectious Diseases, vol. 8, pp. 91 . https://doi.org/10.1186/1471-2334-8-91
BMC Infectious Diseases, Vol 8, Iss 1, p 91 (2008)
Jensen, J-U, Lundgren, B, Hein, L, Mohr, T, Petersen, P L, Andersen, L H, Lauritsen, A O, Hougaard, S, Mantoni, T, Bømler, B, Thornberg, K J, Thormar, K, Løken, J, Steensen, M, Carl, P, Petersen, J A, Tousi, H, Søe-Jensen, P, Bestle, M, Hestad, S, Andersen, M H, Fjeldborg, P, Larsen, K M, Rossau, C D, Thomsen, C B, Ostergaard, C, Kjaer, J, Grarup, J & Lundgren, J D 2008, ' The Procalcitonin And Survival Study (PASS)-a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients ', B M C Infectious Diseases, vol. 8, pp. 91 . https://doi.org/10.1186/1471-2334-8-91
Background Sepsis and complications to sepsis are major causes of mortality in critically ill patients. Rapid treatment of sepsis is of crucial importance for survival of patients. The infectious status of the critically ill patient is often difficul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a886e45ac1c519be48d084099753484b
https://pubmed.ncbi.nlm.nih.gov/18620598
https://pubmed.ncbi.nlm.nih.gov/18620598
Autor:
Lars Nebrich, Jan-Michael Breider, Siv Leivdal, Nanna Reiter, Inga Tjäder, Anders Oldner, Jonathan White, Lars B. Holst, Gudmundur Klemenzson, Hans-Henrik Bülow, Jørgen Wiis, Anders Perner, Rasmus Broby Johansen, Jeanie M. Elkjær, Jørn Wetterslev, Omar Rian, Lasse H. Andersen, Susanne Iversen, Pär I. Johansson, Lone Musaeus Poulsen, Elsebeth Haunstrup, Helle Lykkeskov Nibro, Robert Winding, Per Martin Bådstøløkken, Kristian Strand, Sari Karlsson, Nicolai Haase, Ville Pettilä, Ulf Gøttrup, Carsten Albeck, Ditte Strange, Anders Aneman, Dorte Keld, Peter Roy Casparij Kirkegaard, Jørn-Åge Langva, Jan Wernerman, Niklas Nielsen, Pawel Berezowicz, Katrin Thormar, Asger Bendtsen, Matti Reinikainen, Anne Berit Guttormsen, Marianne L. Vang, Anne Lindhardt, Maria Cronhjort, Morten Steensen, Jane S. Nielsen
Publikováno v:
Trials
Holst, L B, Haase, N, Wetterslev, J, Wernerman, J, Aneman, A, Guttormsen, A B, Johansson, P I, Karlsson, S, Klemenzson, G, Winding, R, Nebrich, L, Albeck, C, Vang, M L, Bülow, H-H, Elkjær, J M, Nielsen, J S, Kirkegaard, P, Nibro, H, Lindhardt, A, Strange, D G, Thormar, K, Poulsen, L M, Berezowicz, P, Bådstøløkken, P M, Strand, K, Cronhjort, M, Haunstrup, E, Rian, O, Oldner, A, Bendtsen, A O, Iversen, S, Langva, J-Å, Johansen, R B, Nielsen, N, Pettilä, V, Reinikainen, M, Keld, D, Leivdal, S, Breider, J-M, Tjäder, I, Reiter, N, Gøttrup, U, White, J O, Wiis, J, Andersen, L H, Steensen, M & Perner, A 2013, ' Transfusion requirements in septic shock (TRISS) trial-comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU : protocol for a randomised controlled trial ', Trials, vol. 14, pp. 150 . https://doi.org/10.1186/1745-6215-14-150
Holst, L B, Haase, N, Wetterslev, J, Wernerman, J, Aneman, A, Guttormsen, A B, Johansson, P I, Karlsson, S, Klemenzson, G, Winding, R, Nebrich, L, Albeck, C, Vang, M L, Bülow, H-H, Elkjær, J M, Nielsen, J S, Kirkegaard, P, Nibro, H, Lindhardt, A, Strange, D G, Thormar, K, Poulsen, L M, Berezowicz, P, Bådstøløkken, P M, Strand, K, Cronhjort, M, Haunstrup, E, Rian, O, Oldner, A, Bendtsen, A O, Iversen, S, Langva, J-Å, Johansen, R B, Nielsen, N, Pettilä, V, Reinikainen, M, Keld, D, Leivdal, S, Breider, J-M, Tjäder, I, Reiter, N, Gøttrup, U, White, J O, Wiis, J, Andersen, L H, Steensen, M & Perner, A 2013, ' Transfusion requirements in septic shock (TRISS) trial-comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU : protocol for a randomised controlled trial ', Trials, vol. 14, pp. 150 . https://doi.org/10.1186/1745-6215-14-150
Transfusion of red blood cells (RBC) is recommended in septic shock and the majority of these patients receive RBC transfusion in the intensive care unit (ICU). However, benefit and harm of RBCs have not been established in this group of high-risk pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24f3b84fb59c2047720013deabbc829f
http://europepmc.org/articles/PMC3679866
http://europepmc.org/articles/PMC3679866